[1]
Slobodyanyuk, V. 2022. Dustarin in the Treatment of Patients with Benign Prostatic Hyperplasia. Health of Man. 1-2 (Jun. 2022), 17–20. DOI:https://doi.org/10.30841/2307-5090.1-2.2022.263898.